Comparative in-vitro activity of erythromycin, vancomycin and pristinamycin
- 1 November 1988
- journal article
- research article
- Published by Springer Nature in Infection
- Vol. 16 (6) , 365-370
- https://doi.org/10.1007/bf01644551
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- In-vitro susceptibility of oral streptococci to pristinamycinJournal of Antimicrobial Chemotherapy, 1987
- A prospective study of adverse reactions associated with vancomycin therapyJournal of Antimicrobial Chemotherapy, 1985
- Erythromycin stearate, 1∣5 g, for the oral prophylaxis of streptococcal bacteraemia in patients undergoing dental extraction: efficacy and toleranceJournal of Antimicrobial Chemotherapy, 1985
- The activity of vancomycin and teicoplanin alone and in combination with gentamicin or ampicillin againstStreptococcus faecalisEuropean Journal of Clinical Microbiology & Infectious Diseases, 1984
- The killing effects of cefathiamidine or ampicillin alone and in combination with gentamicin against with gentamicin against enterococciJournal of Antimicrobial Chemotherapy, 1983
- Defective killing of enterococci: a common property of antimicrobial agents acting on the cell wallAntimicrobial Agents and Chemotherapy, 1980
- Species-Specific Resistance to Antimicrobial Synergism in Streptococcus faecium and Streptococcus faecalisThe Journal of Infectious Diseases, 1979
- Terminology of congenital heart disease. Glossary and commentary.Circulation, 1977
- Synergism of Vancomycin-Gentamicin and Vancomycin-Streptomycin Against EnterococciAntimicrobial Agents and Chemotherapy, 1973
- The estimation of the bactericidal power of the bloodEpidemiology and Infection, 1938